Zhu, Y., Ren, C., Jiang, D., Yang, L., Chen, Y., Li, F., . . . Zhang, Y. (2021). RPL34‐AS1–induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2‐P53 pathway. Cancer Sci.
Chicago-стиль цитированияZhu, Yuanhang, Chenchen Ren, Dongyuan Jiang, Li Yang, Yannan Chen, Feiyan Li, Baojin Wang, and Yali Zhang. "RPL34‐AS1–induced RPL34 Inhibits Cervical Cancer Cell Tumorigenesis Via the MDM2‐P53 Pathway." Cancer Sci 2021.
MLA-цитированиеZhu, Yuanhang, et al. "RPL34‐AS1–induced RPL34 Inhibits Cervical Cancer Cell Tumorigenesis Via the MDM2‐P53 Pathway." Cancer Sci 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.